Analyst Reco. H. Lundbeck A/S

Equities

HLUN B

DK0061804770

Pharmaceuticals

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 10/04/2026 BST			5-day change	1st Jan Change
40.38 ^DKK	+1.36%		-0.98%	-6.44%

03-23	H. Lundbeck Price Target Down as AlphaValue/Baader Europe Expects Patent Expirations to Weigh on Growth	MT
03-20	H Lundbeck: Markets need more proof of growth promise

Analyst Reco.

03-23	H. Lundbeck Price Target Down as AlphaValue/Baader Europe Expects Patent Expirations to Weigh on Growth	MT
03-20	H Lundbeck: Markets need more proof of growth promise
03-05	Nordea Resumes Coverage of Lundbeck With Buy Rating – Too Cheap to Ignore	FW
03-05	Nordea Resumes Coverage of Lundbeck with Buy Rating and Price Target of 55 Danish Kroner	FW
03-02	Jefferies Upgrades Lundbeck to Hold (Underperform), Sets Price Target at 39 Danish Kroner	FW
02-17	Deutsche Bank Lowers Price Target for Lundbeck to 40 Danish Kroner (44), Maintains Hold Recommendation	FW
02-16	DNB Carnegie Raises Price Target for Lundbeck to 53 Danish Kroner (51), Reiterates Buy	FW
02-12	Barclays Lowers Price Target for Lundbeck to 45 Danish Kroner (from 50), Maintains Equal Weight - BN	FW
02-06	H Lundbeck: Weak 2026 outlook a turn-off for investors
02-05	Danske Bank Lowers Price Target for Lundbeck to 48 Danish Kroner (52), Reiterates Buy - BN	FW
02-05	UBS Lowers Price Target for Lundbeck to 42 Danish Kroner (46), Reiterates Neutral Rating	FW
02-05	SEB Lowers Price Target for Lundbeck to 43 Danish Kroner (from 50), Maintains Hold Recommendation	FW
01-29	DNB Carnegie Lowers Price Target for Lundbeck to 51 Danish Kroner (53), Reiterates Buy	FW
01-20	Danske Bank Lowers Price Target for Lundbeck to 52 Danish Kroner (55), Reiterates Buy - BN	FW
01-07	Barclays Lowers Price Target for Lundbeck to 50 Danish Kroner (from 53), Maintains Equal Weight - BN	FW
12-03	BNP Paribas Exane Raises Price Target for Lundbeck to 45 Danish Kroner, Reiterates Neutral Rating - BN	FW
11-20	UBS Raises Lundbeck Target Price to 46 Danish Kroner, Maintains Neutral Rating	FW
11-18	Barclays Raises Price Target for Lundbeck to 53 Danish Kroner, Reiterates Equal Weight	FW
11-14	H Lundbeck lifts guidance again as migraine and depression drugs drive growth
11-13	Kepler Cheuvreux Raises Target Price for Lundbeck to 65 Danish Kroner, Reiterates Buy	FW
11-13	SEB Raises Price Target for Lundbeck to 50 Danish Kroner, Reiterates Hold	FW
11-12	Nordea Raises Target Price for Lundbeck to 72 Danish Kroner (71), Reiterates Buy	FW
11-11	Jefferies Downgrades Lundbeck on Patent Concerns	FW
11-11	Jefferies Downgrades Lundbeck to Underperform, Lowers Target Price to 39 Danish Kroner	FW
11-10	Lundbeck Expected to Report DKK 1,844 Million in Adjusted EBITDA - Consensus	FW